Cautious interpretation of HVD's pilot study [Design Issues]

posted by rafimmc – 2007-07-20 08:17 (6914 d 09:36 ago) – Posting: # 914
Views: 4,371

Dear Sir,
Yes. The sample size was 18. Can we expect a multiple dose study with 64 subjects to give lesser variablity and thus increasing the chances of demonstrating bioequivalence? Please suggest.

Thanks adn regards,
Rafimmc

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
138 visitors (0 registered, 138 guests [including 21 identified bots]).
Forum time: 17:53 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5